Venus Medtech Appoints Professor Martin B. Leon as Global Principal Investigator of Its New-Generation RDN System
On July 27, 2021, Venus Medtech (Hangzhou) Inc. (“Venus Medtech”) (stock code: 2500.HK), a leading provider of comprehensive interventional heart valve therapy solutions in China, and its…
